Correlation Engine 2.0
Clear Search sequence regions


  • berlin (1)
  • boston (1)
  • control groups (1)
  • dmso (3)
  • h 89 (9)
  • impairs (2)
  • rats (3)
  • Sizes of these terms reflect their relevance to your search.

    H-89 (a protein kinase AII [PKA II] inhibitor) impairs the spatial memory in the Morris water maze task in rats. In the present study, we aimed to study the protective effects of nicotine and O-acetyl-L-carnitine against H-89-induced spatial memory deficits. Spatial memory impairment was induced by the bilateral intrahippocampal administration of 10 µM H-89 (dissolved in dimethyl sulfoxide, DMSO) to rats. The rats then received bilateral administrations of either nicotine (1 μg/μL, dissolved in saline) or O-acetyl-L-carnitine (100 μM/side, dissolved in deionized water) alone and in combination. Control groups received either saline, deionized water, or DMSO. The H-89-treated animals showed significant increases in the time and distance travelled to find hidden platforms, and there was also a significant decrease in the time spent in the target quadrant compared to DMSO-treated animals. Nicotine and O-acetyl-L-carnitine had no significant effects on H-89-induced spatial learning impairments alone, but the bilateral intrahippocampal co-administration of nicotine and O-acetyl-L-carnitine prevented H-89-induced spatial learning deficits and increased the time spent in the target quadrant in comparison with H-89-treated animals. Our results indicated the potential synergistic effects of nicotine and O-acetyl-L-carnitine in preventing protein kinase AII inhibitor (H-89)-induced spatial learning impairments. © 2021 Walter de Gruyter GmbH, Berlin/Boston.

    Citation

    Mahmoud Hashemzaei, Najmeh Baratzadeh, Iraj Shahramian, Sahar Fanoudi, Mehdi Sanati, Hanieh Rezaei, Jafar Shahraki, Ramin Rezaee, Maryam Belaran, Ali Bazi, Kaveh Tabrizian. Intrahippocampal co-administration of nicotine and O-acetyl-L-carnitine prevents the H-89-induced spatial learning deficits in Morris water maze. Journal of complementary & integrative medicine. 2022 Sep 01;19(3):691-696


    PMID: 33964190

    View Full Text